Matthew Harrison
Stock Analyst at Susquehanna
(3.49)
# 887
Out of 5,148 analysts
711
Total ratings
50%
Success rate
4.32%
Average return
Main Sectors:
Stocks Rated by Matthew Harrison
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| R Ryder System | Maintains: Positive | $235 → $250 | $221.43 | +12.90% | 2 | Feb 13, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintains: Equal-Weight | $768 → $769 | $790.81 | -2.76% | 59 | Feb 2, 2026 | |
| INSM Insmed | Maintains: Equal-Weight | $157 → $162 | $146.32 | +10.72% | 20 | Jan 30, 2026 | |
| GILD Gilead Sciences | Maintains: Overweight | $151 → $150 | $150.03 | -0.02% | 44 | Jan 13, 2026 | |
| MRNA Moderna | Maintains: Equal-Weight | $30 → $28 | $52.85 | -47.01% | 27 | Dec 12, 2025 | |
| LEGN Legend Biotech | Maintains: Overweight | $83 → $50 | $18.45 | +171.08% | 14 | Dec 12, 2025 | |
| BIIB Biogen | Maintains: Equal-Weight | $149 → $156 | $188.05 | -17.04% | 56 | Dec 12, 2025 | |
| ARGX argenx SE | Maintains: Overweight | $1,070 → $1,110 | $756.76 | +46.68% | 27 | Dec 4, 2025 | |
| PHVS Pharvaris | Maintains: Overweight | $37 → $41 | $28.00 | +46.43% | 16 | Dec 4, 2025 | |
| ZNTL Zentalis Pharmaceuticals | Maintains: Equal-Weight | $8 → $4 | $2.50 | +60.00% | 5 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $104 → $98 | $59.74 | +64.04% | 23 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $33 → $30 | $21.00 | +42.86% | 13 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $6 → $4 | $0.33 | +1,114.33% | 6 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $460 → $439 | $486.03 | -9.68% | 41 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $20 | $16.32 | +22.55% | 38 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6.2 → $6 | $4.87 | +23.20% | 10 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $5 | $0.57 | +777.19% | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $56 | $40.88 | +36.99% | 2 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $57 → $55 | $30.82 | +78.46% | 2 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $10 → $3 | $2.21 | +35.75% | 10 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $8 → $11 | $26.51 | -58.51% | 9 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $7 | $2.15 | +225.58% | 18 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $32 | $29.65 | +7.93% | 27 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $19 | $4.66 | +307.73% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2 → $1 | $1.72 | -41.86% | 3 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $10 | $22.83 | -56.20% | 9 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $27 → $8 | $7.81 | +2.43% | 9 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $57 → $44 | $34.09 | +29.07% | 28 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $13 | $4.15 | +213.25% | 3 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $140 → $80 | $24.10 | +231.95% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $100 → $60 | $4.53 | +1,224.50% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $203 → $216 | $107.48 | +100.97% | 8 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $5 | $4.18 | +19.62% | 13 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $2.96 | +68.92% | 6 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $178 → $182 | $234.26 | -22.31% | 8 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $9 | $27.36 | -67.11% | 13 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $282 | $385.70 | -26.89% | 38 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $220 → $210 | $325.07 | -35.40% | 7 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $52 | $27.26 | +90.76% | 5 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $175 → $173 | $248.56 | -30.40% | 3 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $156 → $120 | $23.02 | +421.29% | 17 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $145 → $148 | $11.81 | +1,153.18% | 19 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $88 → $82 | $121.41 | -32.46% | 4 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $71 → $66 | $62.34 | +5.87% | 4 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $43 → $39 | $4.53 | +760.93% | 4 | Aug 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $46 | $47.47 | -3.10% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $35 | $7.19 | +386.79% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $207 → $275 | $1,017.97 | -72.99% | 2 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $2.79 | +581.00% | 1 | Jun 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $67 → $62 | $9.24 | +571.00% | 12 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $16.97 | +1.65% | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $89 → $83 | $100.04 | -17.03% | 1 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Equal-Weight | $10 | $61.43 | -83.72% | 4 | Sep 10, 2018 |
Ryder System
Feb 13, 2026
Maintains: Positive
Price Target: $235 → $250
Current: $221.43
Upside: +12.90%
Regeneron Pharmaceuticals
Feb 2, 2026
Maintains: Equal-Weight
Price Target: $768 → $769
Current: $790.81
Upside: -2.76%
Insmed
Jan 30, 2026
Maintains: Equal-Weight
Price Target: $157 → $162
Current: $146.32
Upside: +10.72%
Gilead Sciences
Jan 13, 2026
Maintains: Overweight
Price Target: $151 → $150
Current: $150.03
Upside: -0.02%
Moderna
Dec 12, 2025
Maintains: Equal-Weight
Price Target: $30 → $28
Current: $52.85
Upside: -47.01%
Legend Biotech
Dec 12, 2025
Maintains: Overweight
Price Target: $83 → $50
Current: $18.45
Upside: +171.08%
Biogen
Dec 12, 2025
Maintains: Equal-Weight
Price Target: $149 → $156
Current: $188.05
Upside: -17.04%
argenx SE
Dec 4, 2025
Maintains: Overweight
Price Target: $1,070 → $1,110
Current: $756.76
Upside: +46.68%
Pharvaris
Dec 4, 2025
Maintains: Overweight
Price Target: $37 → $41
Current: $28.00
Upside: +46.43%
Zentalis Pharmaceuticals
Nov 12, 2025
Maintains: Equal-Weight
Price Target: $8 → $4
Current: $2.50
Upside: +60.00%
Oct 28, 2025
Maintains: Overweight
Price Target: $104 → $98
Current: $59.74
Upside: +64.04%
Aug 18, 2025
Maintains: Overweight
Price Target: $33 → $30
Current: $21.00
Upside: +42.86%
Aug 12, 2025
Maintains: Overweight
Price Target: $6 → $4
Current: $0.33
Upside: +1,114.33%
Aug 5, 2025
Maintains: Equal-Weight
Price Target: $460 → $439
Current: $486.03
Upside: -9.68%
Jul 29, 2025
Maintains: Equal-Weight
Price Target: $15 → $20
Current: $16.32
Upside: +22.55%
Apr 11, 2025
Maintains: Equal-Weight
Price Target: $6.2 → $6
Current: $4.87
Upside: +23.20%
Mar 12, 2025
Maintains: Overweight
Price Target: $15 → $5
Current: $0.57
Upside: +777.19%
Feb 18, 2025
Upgrades: Buy
Price Target: $56
Current: $40.88
Upside: +36.99%
Jan 31, 2025
Maintains: Buy
Price Target: $57 → $55
Current: $30.82
Upside: +78.46%
Nov 26, 2024
Downgrades: Underweight
Price Target: $10 → $3
Current: $2.21
Upside: +35.75%
Jun 21, 2024
Maintains: Equal-Weight
Price Target: $8 → $11
Current: $26.51
Upside: -58.51%
May 9, 2024
Upgrades: Equal-Weight
Price Target: $7
Current: $2.15
Upside: +225.58%
Mar 26, 2024
Maintains: Underweight
Price Target: $32
Current: $29.65
Upside: +7.93%
Aug 14, 2023
Maintains: Equal-Weight
Price Target: $21 → $19
Current: $4.66
Upside: +307.73%
Mar 27, 2023
Maintains: Underweight
Price Target: $2 → $1
Current: $1.72
Upside: -41.86%
Mar 3, 2023
Maintains: Underweight
Price Target: $13 → $10
Current: $22.83
Upside: -56.20%
Feb 28, 2023
Downgrades: Equal-Weight
Price Target: $27 → $8
Current: $7.81
Upside: +2.43%
Feb 27, 2023
Maintains: Equal-Weight
Price Target: $57 → $44
Current: $34.09
Upside: +29.07%
Jan 24, 2023
Maintains: Overweight
Price Target: $15 → $13
Current: $4.15
Upside: +213.25%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $140 → $80
Current: $24.10
Upside: +231.95%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $100 → $60
Current: $4.53
Upside: +1,224.50%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $203 → $216
Current: $107.48
Upside: +100.97%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $4.18
Upside: +19.62%
Jan 24, 2023
Maintains: Overweight
Price Target: $7 → $5
Current: $2.96
Upside: +68.92%
Dec 6, 2022
Maintains: Overweight
Price Target: $178 → $182
Current: $234.26
Upside: -22.31%
Nov 14, 2022
Maintains: Equal-Weight
Price Target: $12 → $9
Current: $27.36
Upside: -67.11%
Nov 4, 2022
Maintains: Overweight
Price Target: $279 → $282
Current: $385.70
Upside: -26.89%
Oct 28, 2022
Maintains: Equal-Weight
Price Target: $220 → $210
Current: $325.07
Upside: -35.40%
May 4, 2022
Maintains: Equal-Weight
Price Target: $55 → $52
Current: $27.26
Upside: +90.76%
Apr 6, 2022
Maintains: Equal-Weight
Price Target: $175 → $173
Current: $248.56
Upside: -30.40%
Feb 1, 2022
Maintains: Overweight
Price Target: $156 → $120
Current: $23.02
Upside: +421.29%
Jan 7, 2022
Maintains: Equal-Weight
Price Target: $145 → $148
Current: $11.81
Upside: +1,153.18%
Nov 29, 2021
Maintains: Equal-Weight
Price Target: $88 → $82
Current: $121.41
Upside: -32.46%
Oct 12, 2021
Maintains: Equal-Weight
Price Target: $71 → $66
Current: $62.34
Upside: +5.87%
Aug 18, 2021
Maintains: Overweight
Price Target: $43 → $39
Current: $4.53
Upside: +760.93%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $51 → $46
Current: $47.47
Upside: -3.10%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $33 → $35
Current: $7.19
Upside: +386.79%
Aug 5, 2021
Maintains: Overweight
Price Target: $207 → $275
Current: $1,017.97
Upside: -72.99%
Jun 24, 2021
Initiates: Buy
Price Target: $19
Current: $2.79
Upside: +581.00%
Mar 8, 2021
Maintains: Overweight
Price Target: $67 → $62
Current: $9.24
Upside: +571.00%
Feb 24, 2021
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $16.97
Upside: +1.65%
Jan 6, 2020
Maintains: Equal-Weight
Price Target: $89 → $83
Current: $100.04
Upside: -17.03%
Sep 10, 2018
Assumes: Equal-Weight
Price Target: $10
Current: $61.43
Upside: -83.72%